Attenuated measles virus as a vaccine vector.

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Live attenuated measles virus (MV) vaccines are highly safe and effective, providing lifelong immunity.
• Reverse genetics enables the rescue of negative-strand RNA viruses from cloned DNA, facilitating genetic manipulation.
• MV's cytoplasmic replication and lack of DNA intermediate offer significant biosafety advantages for vector development.

Purpose of the Study:

• To characterize reporter gene expression (GFP, LacZ, CAT) in recombinant MV.
• To evaluate the biochemical, biophysical, and immunological properties of recombinant MV expressing simian immunodeficiency virus (SIV) antigens.
• To assess the potential of MV as a flexible vector system for inducing broad immune responses.

Main Methods:

• Utilizing reverse genetics technology to engineer recombinant MV strains.
• Insertion of exogenous genes encoding foreign antigens (SIV antigens) into the MV genome.
• Analysis of reporter gene expression and assessment of recombinant MV properties.

Main Results:

• Recombinant MV successfully expressed reporter genes (GFP, LacZ, CAT).
• Recombinant MV expressing SIV antigens demonstrated specific biochemical, biophysical, and immunological characteristics.
• The engineered MV strains induced immune responses against both MV and the heterologous SIV antigens.

Conclusions:

• Recombinant MV is a viable and flexible vector for expressing foreign antigens.
• MV-based vectors can elicit immune responses against both the vector and the inserted antigens.
• The safety profile and genetic tractability of MV support its use in developing novel vaccine strategies.